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Abstract 
Review on WNT1, with data on DNA/RNA, on the 
protein encoded and where the gene is implicated. 
Identity 
Other names: BMND16, INT1, OI15 
HGNC (Hugo): WNT1 
Location: 12q13.12 
DNA/RNA 
Description 
The WNT1 gene spans a genomic region of 4161 
bases on plus strand.  
The DNA of WNT1 consists of 4 exons and the 
coding sequence starts in the first exon. 
Transcription 
The WNT1 gene has one protein coding transcript 
which consists of 370 amino acids. 
Protein 
Description 
Ligand for members of the frizzled family of seven  
 
 
transmembrane receptors.  
In some developmental processes, is also a ligand 
for the coreceptor RYK, thus triggering Wnt 
signaling. 
Localisation 
Secreted, extracellular space, extracellular matrix. 
Function 
Probable developmental protein.  
May be a signaling molecule important in CNS 
(central nervous system) development.  
Is likely to signal over only few cell diameters.  
Has a role in osteoblast function and bone 
development. 
Mutations 
Somatic 
There are several WNT1 mutations identified 
related with osteogenesis imperfecta.  
Several confirmed somatic mutations of the WNT1 
gene have also been reported, according to 
COSMIC, which are associated with carcinomas of 
the endometrium, lung, large intestine, prostate and 
kidney. 
 
 
Genomic location of WNT1 gene at chromosome 12 (plus strand). 
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Implicated in 
Esophageal cancer 
Note 
It has been shown, in cell cultures of esophageal 
cancer, that WNT1 results in cytoplasmic 
accumulation of beta-catenin and activates TCF-
dependent transcription (Mizushima et al., 2002). 
Overexpression of mRNA and protein levels of 
WNT1 have been positively associated with lymph 
node metastasis, advanced pathological stage and 
prognosis of patients with esophageal squamous 
cell carcinoma (Lv et al., 2012). 
Breast cancer 
Note 
WNT1 has been shown to be markedly elevated in 
grade I tumors, but declined as tumor grade 
declined (Wong et al., 2002). Ectopic expression of 
WNT1, triggers the DNA damage response (DDR) 
and an ensuing cascade of events resulting in 
tumorigenic conversion of primary human 
mammary epithelial cells. WNT1-transformed cells 
have high telomerase activity and compromised p53 
and Rb function, grow as spheres in suspension, 
and in mice form tumors that closely resemble 
medullary carcinomas of the breast (Ayyanan et al., 
2006). siRNA anti-WNT1 has been shown to 
induce apoptosis in human breast cancer cell lines 
(Wieczorek et al., 2008). WNT1 immunoreactivity 
has been found to be inversely related to 
histological grade, Ki-67 and p53, positively to , 
HER-2 and caspase-3 and has been correlated with 
favorable prognosis of patients with stage II breast 
cancer (Mylona et al., 2013). 
Basal cell carcinoma of head and 
neck 
Note 
Overexpression of WNT1 has been positively 
associated with cytoplasmic beta-catenin (Lo Muzio 
et al., 2002). 
Sarcoma 
Note 
WNT1 blockade by either monoclonal antibody or 
siRNA induces cell death in sarcoma cells (Mikami 
et al., 2005). 
Non-small cell lung cancer (NSCLC) 
Note 
The expression of WNT1 has been positively 
correlated with c-Myc, cyclin D1, VEGF-A, MMP-
7, Ki-67 and intratumoral microvessel density and 
has been found to negatively influence patients' 
survival (Huang et al., 2008). WNT1 
overexpression has been positively associated with 
the Ki-67 proliferation index and c-Myc and has 
been found to exert an unfavorable impact on 
patients' survival (Nakashima et al., 2008). WNT1 
expression has been found to be an independent 
prognostic factor of poor survival (Xu et al., 2011). 
Gastric cancer 
Note 
The expression levels of WNT1 are positively 
correlated with tumor size, tumor invasive depth, 
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lymph node metastasis, pTNM stage and negatively 
influences patients' 5-year survival rate (Zhang and 
Xue, 2008). 
Neuroblastoma 
Note 
Knockdown of endogenous WNT1 expression 
results in cell death and inhibits cell growth (Zhang 
et al., 2009). 
Osteogenesis imperfecta (OI) 
Note 
This disease is a heritable bone fragiility disorder 
that is usually due to dominant mutations in 
COL1A1 or COL1A2 and is characterized by 
reduced bone mass and recurrent fractures. Genetic 
variations in WNT1 define the bone mineral density 
quantitative trait locus 16 (BMND16) 
[MIM:615221]. Variance in bone mineral density 
influences bone mass, contributes to size 
determination in the general population, and is a 
susceptibility factor for osteoporotic fractures. The 
disease is caused by mutations affecting the gene of 
WNT1 (Fahiminiya et al., 2013; Faqeih et al., 2013; 
Laine et al., 2013; Pyott et al., 2013). 
Osteoporosis (OSTEOP) 
Note 
A systemic skeletal disorder characterized by 
decreased bone mass and deterioration of bone 
microarchitecture without alteration in the 
composition of bone. The result is fragile bones and 
an increased risk of fractures, even after minimal 
trauma. Osteoporosis is a chronic condition of 
multifactorial etiology and is usually clinically 
silent until a fracture occurs. Disease susceptibility 
is associated with variations affecting the gene of 
WNT1 (Keupp et al., 2013; Laine et al., 2013). 
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